Your browser is no longer supported. Please, upgrade your browser. Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Order: Signal: Tickers:
Filters: 0    Descriptive       Fundamental       Technical       All   
Exchange Index Sector Industry Country
Market Cap. Dividend Yield Float Short Analyst Recom. Option/Short
Earnings Date Average Volume Relative Volume Current Volume Price
Overview Valuation Financial Ownership Performance Technical Custom Charts Tickers Quotes Basic TA News Snapshot
Total: 9 #1
CompanyAviat Networks, Inc.
IndustryCommunication Equipment
Market Cap96.33MEPS (ttm)-0.70
P/E-EPS this Y-361.10%
Forward P/E32.98EPS next Y138.50%
PEG-EPS past 5Y32.50%
P/S0.29EPS next 5Y12.00%
P/B1.00EPS Q/Q54.50%
Dividend-Sales Q/Q-11.80%
Insider Own0.40%Inst Own67.80%
Insider Trans21.16%Inst Trans5.47%
Short Float1.91%EarningsDec 10/a
Analyst Recom2.00Target Price2.15
Avg Volume293.13K52W Range0.99 - 2.42
Dec-22-14 06:02AMAVIAT NETWORKS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
Dec-22-14 06:02AMAVIAT NETWORKS, INC. Files SEC form 10-K, Annual Report EDGAR Online
Dec-15-14 09:00AMSafaricom Renews Key Supplier Agreement with Aviat PR Newswire
Dec-10-14 04:30PMAviat Networks Inc Earnings Call scheduled for 4:30 pm ET today CCBN
Dec-10-14 04:21PMAviat reports 1Q loss AP
Dec-10-14 04:10PMAVIAT NETWORKS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
Dec-10-14 04:05PMAviat Networks Announces Preliminary Fiscal First Quarter 2015 Financial Results PR Newswire
Dec-10-14 07:07AMQ1 2015 Aviat Networks Inc Earnings Release - After Market Close CCBN
Dec-03-14 06:09PMAviat Networks Schedules Release of Preliminary First Quarter of Fiscal 2015 Financial Results for December 10, 2014; Submits Plan of Compliance to NASDAQ PR Newswire
Nov-13-14 09:00AMAviat Releases Industry's Highest Power Microwave Radio PR Newswire
Aviat Networks, Inc. designs, manufactures, and sells a range of wireless networking products, solutions, and services in North America and Internationally. It offers point-to-point digital microwave transmission systems for first/last mile access, middle mile/backhaul, and long distance trunking applications. The company's products include network management software solutions to enable operators to deploy, monitor, and manage its systems, as well as third party equipment, such as antennas, routers, and multiplexers to build and deploy a wireless transmission network and a suite of turnkey support services. It also provides broadband wireless access base stations and customer premises equipment for fixed and mobile; point-to-point digital microwave radio systems for access, backhaul, trunking, and license-exempt applications; and supporting network deployments, network expansion, and capacity upgrades. In addition, the company offers various professional services, such as network planning and design, site surveys and builds, systems integration, installation, maintenance, network monitoring, training, and customer services. It serves wireless/mobile service providers, original equipment manufacturers, distributors, and system integrators; and private network users, such as public safety agencies and government institutions; and utility, pipeline, railroad, and other industrial enterprises that operate broadband wireless networks. The company was formerly known as Harris Stratex Networks, Inc. and changed its name to Aviat Networks, Inc. in January 2010. Aviat Networks, Inc. is headquartered in Santa Clara, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stumpe HeinzSVP & Chief Sales OfficerSep 09Sale1.532,4013,674116,980Sep 10 02:18 PM
Elliott Meena L.SVP, Gen. Counsel & SecretarySep 09Sale1.531,5842,42499,632Sep 10 02:19 PM
Madigan JohnVP, Corporate Controller & PAOSep 09Sale1.531,0051,53851,829Sep 10 02:17 PM
Stumpe HeinzSVP & Chief Sales OfficerJun 30Sale1.205,4926,593119,381Jul 01 12:36 PM
Elliott Meena L.SVP, Gen. Counsel & SecretaryJun 30Sale1.202,9063,488101,216Jul 01 12:35 PM
CompanyDyax Corp.
Market Cap2.11BEPS (ttm)-0.09
P/E-EPS this Y13.30%
Forward P/E-EPS next Y63.60%
PEG-EPS past 5Y24.80%
P/S29.01EPS next 5Y18.60%
P/B20.05EPS Q/Q83.30%
Dividend-Sales Q/Q60.60%
Insider Own8.78%Inst Own97.80%
Insider Trans-1.62%Inst Trans2.20%
Short Float4.64%EarningsOct 28
Analyst Recom1.60Target Price14.06
Avg Volume1.08M52W Range6.05 - 15.53
Dec-10-14 06:17AMCan Dyax (DYAX) Keep the Earnings Streak Alive This Quarter? Zacks
Dec-03-14 07:00AMDyax Corp. to Participate in the 25th Annual Oppenheimer Healthcare Conference Business Wire
Nov-24-14 10:00AMStrong On High Relative Volume: Dyax (DYAX) at TheStreet
Nov-18-14 07:30AMDyax Corp. Recognized as a Top Place to Work by The Boston Globe Business Wire
Nov-07-14 05:50AMWhy Dyax (DYAX) Could Be Positioned for a Surge? Zacks
Nov-05-14 07:08PM10-Q for Dyax Corp. Company Spotlight
Nov-04-14 05:46AMCan Dyax (DYAX) Stock Continue to Grow Earnings? Zacks
Nov-03-14 04:31PMDYAX CORP Files SEC form 10-Q, Quarterly Report EDGAR Online
Nov-03-14 07:30AMDyax Corp. Announces Expansion of Phase 1b Clinical Trial for DX-2930 Business Wire
Oct-30-14 08:05AMWill Dyax (DYAX) Continue to Surge Higher? Zacks
Dyax Corp., a biopharmaceutical company, identifies, develops, and commercializes treatments for hereditary angioedema (HAE) and plasma kallikrein-mediated (PKM) angioedemas. The company offers KALBITOR for the treatment of acute attacks of HAE. It is developing DX-2930, a human monoclonal antibody inhibitor of plasma kallikrein, which would be a candidate to prophylactically treat HAE and other PKM disorders. The company distributes KALBITOR through a network of wholesale and specialty pharmacy arrangements. It has agreements with CVie Therapeutics for the development and commercialization of KALBITOR in the treatment of HAE and other angioedema indications in China; and Novellus Biopharma AG for the development and commercialization of KALBITOR for the treatment of HAE and other angioedema indications in Latin America, including Argentina, Brazil, Chile, Colombia, Mexico, and Venezuela. The company also has a strategic collaboration agreement with Sigma-Tau Rare Diseases S.A. to develop and commercialize subcutaneous ecallantide for the treatment of HAE and other therapeutic indications in Europe, North Africa, the Middle East, and Russia. Dyax Corp. was founded in 1989 and is headquartered in Burlington, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KEMPNER THOMAS LDirectorNov 21Sale13.20100,0001,319,910617,120Nov 24 04:26 PM
MCLACHLAN DAVID JDirectorNov 20Option Exercise3.8213,00049,66042,100Nov 24 04:15 PM
MCLACHLAN DAVID JDirectorNov 20Sale13.1113,000170,46929,100Nov 24 04:15 PM
KEMPNER THOMAS LDirectorSep 12Sale11.004,90053,900717,120Sep 15 04:29 PM
KEMPNER THOMAS LDirectorSep 11Sale11.007,50082,500722,020Sep 15 04:29 PM
TickerKOS [NYSE]
CompanyKosmos Energy Ltd.
IndustryIndependent Oil & Gas
Market Cap3.12BEPS (ttm)0.40
P/E20.17EPS this Y-33.30%
Forward P/E-EPS next Y-120.70%
PEG0.88EPS past 5Y-4.80%
P/S3.48EPS next 5Y22.85%
P/B2.58EPS Q/Q141.70%
Dividend-Sales Q/Q-35.70%
Insider Own4.00%Inst Own53.80%
Insider Trans-86.50%Inst Trans5.29%
Short Float2.01%EarningsNov 03/b
Analyst Recom2.30Target Price12.66
Avg Volume2.18M52W Range6.96 - 11.60
Nov-21-14 10:01AMTrade-Ideas: Kosmos Energy (KOS) Is Today's Strong On High Relative Volume Stock at TheStreet
Nov-14-14 01:04PMKOSMOS ENERGY LTD. Financials EDGAR Online Financials
Nov-07-14 06:30AMKosmos Energy upgraded by RBC Capital Mkts
Nov-03-14 11:00AMKosmos Energy Ltd Earnings Call scheduled for 11:00 am ET today CCBN
Nov-03-14 07:09AMKosmos Energy misses 3Q profit forecasts AP
Nov-03-14 07:07AMQ3 2014 Kosmos Energy Ltd Earnings Release - Before Market Open CCBN
Nov-03-14 07:00AMKosmos Energy Announces Third Quarter 2014 Results Business Wire
Nov-03-14 06:59AMKOSMOS ENERGY LTD. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Finan EDGAR Online
Oct-27-14 10:00AMWarburg Pincus Completes $4 Billion Global Private Equity Energy Fundraise PR Newswire
Oct-17-14 05:59AMKOSMOS ENERGY LTD. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Financial EDGAR Online
Kosmos Energy Ltd. explores and produces oil and gas in Africa, Europe, and South America. Its asset portfolio includes production and other projects offshore Ghana, as well as exploration licenses with hydrocarbon potential offshore Ireland, Mauritania, Morocco, and Suriname. The company was founded in 2003 and is based in Hamilton, Bermuda.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BCP IV GP L.L.C.10% OwnerOct 10Sale9.336,749,99562,977,453270,001Oct 10 05:36 PM
Blackstone Holdings III L.P.10% OwnerOct 10Sale9.336,750,00062,977,500270,001Oct 10 05:35 PM
WARBURG PINCUS & CO.DirectorOct 10Sale9.337,951,43774,186,90756,556,832Oct 15 01:50 PM
WARBURG PINCUS & CO.DirectorOct 10Sale9.3316,500,000153,945,000118,008,651Oct 15 01:50 PM
Krieger David BenjaminDirectorOct 10Sale9.338,250,00076,972,500118,008,651Oct 15 01:54 PM
CompanyMaiden Holdings, Ltd.
IndustryProperty & Casualty Insurance
Market Cap947.10MEPS (ttm)0.89
P/E14.60EPS this Y79.70%
Forward P/E7.16EPS next Y21.84%
PEG1.22EPS past 5Y29.20%
P/S0.42EPS next 5Y12.00%
P/B1.05EPS Q/Q20.00%
Dividend4.00%Sales Q/Q16.70%
Insider Own0.20%Inst Own71.70%
Insider Trans19.70%Inst Trans2.23%
Short Float6.20%EarningsNov 05/a
Analyst Recom1.50Target Price15.33
Avg Volume363.30K52W Range10.26 - 13.52
Dec-19-14 09:56AMAlistair Capital Delivers Letter to AmTrust Financial Services, Inc.'s Audit Committee PR Newswire
Nov-21-14 01:04PMMAIDEN HOLDINGS, LTD. Financials EDGAR Online Financials
Nov-17-14 04:24PMMAIDEN HOLDINGS, LTD. Files SEC form 8-K, Regulation FD Disclosure EDGAR Online
Nov-13-14 03:41PMMaiden Holdings (MHLD) & CNB Financial (CCNE): This Week's Growth & Income Stocks Zacks
Nov-13-14 05:49AMWhy Maiden Holdings (MHLD) Could Be a Top Value Stock Pick Zacks
Nov-12-14 07:09PM10-Q for Maiden Holdings Ltd. Company Spotlight
Nov-10-14 05:18PMMAIDEN HOLDINGS, LTD. Files SEC form 10-Q, Quarterly Report EDGAR Online
Nov-07-14 02:13PMMaiden Holdings (MHLD) Shares Rise on Dividend Increase Zacks
Nov-06-14 06:07AMMAIDEN HOLDINGS, LTD. Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online
Nov-05-14 07:46PMMaiden Holdings posts 3Q profit AP
Maiden Holdings, Ltd., together with its subsidiaries, provides reinsurance solutions to regional and specialty insurers in the United States, Europe, and internationally. The company operates through three segments: Diversified Reinsurance, AmTrust Quota Share Reinsurance, and NGHC Quota Share. The Diversified Reinsurance segment offers property, casualty, accident, and health reinsurance products through the treaties with other insurers on a quota share or excess of loss basis, as well as on a facultative basis primarily through third-party intermediaries and on a direct basis. The AmTrust Quota Share Reinsurance segment provides small commercial business insurance, which includes workers' compensation, commercial package, and other property and casualty insurance products; specialty risk and extended warranty coverage for consumer and commercial goods, as well as custom designed coverage, including accidental damage plans and payment protection plans in connection with the sale of consumer and commercial goods; and specialty program that comprises package products, general liability, commercial auto liability, excess and surplus lines programs, and other specialty commercial property and casualty insurance to small and middle market companies. The NGHC Quota Share segment reinsures personal lines automobile business under the quota share reinsurance agreement. The company also offers credit life reinsurance. The company was founded in 2007 and is headquartered in Hamilton, Bermuda.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SCHMITT KARENChief Financial OfficerSep 03Option Exercise4.0024,17596,610111,324Sep 03 04:03 PM
NEFF RAYMOND MICHAELDirectorMar 27Option Exercise0.0024,0000249,000Mar 28 06:55 AM
MARSHALECK JOHNCHIEF FINANCIAL OFFICERMar 21Option Exercise3.2825,00082,00079,730Mar 24 05:04 PM
RASCHBAUM ARTURO MANUELPRESIDENT AND CEOFeb 18Option Exercise0.00136,6050270,892Feb 20 04:20 PM
TickerMR [NYSE]
CompanyMindray Medical International Limited
IndustryMedical Instruments & Supplies
Market Cap3.16BEPS (ttm)1.84
P/E14.65EPS this Y24.70%
Forward P/E13.44EPS next Y11.08%
PEG6.72EPS past 5Y14.30%
P/S2.45EPS next 5Y2.18%
P/B2.06EPS Q/Q56.00%
Dividend1.86%Sales Q/Q9.60%
Insider Own1.93%Inst Own-
Insider Trans-Inst Trans-1.95%
Short Float16.92%EarningsNov 03/a
Analyst Recom2.60Target Price32.36
Avg Volume682.26K52W Range26.58 - 40.26
Dec-12-14 05:00PMMindray Announced Shareholder Resolutions Post 2014 Annual General Meeting PR Newswire
Nov-24-14 07:30AMAmerican Biotech Start-Ups Head To China For Capital Partners at Forbes
Nov-13-14 06:00AMMindray to Hold Annual General Meeting in Hong Kong on December 10, 2014 PR Newswire
Nov-04-14 02:10PMMindray Medical Q3 Earnings in Line, 2014 View Lowered Zacks
Nov-04-14 08:00AMMindray Medical International Ltd Earnings Call scheduled for 8:00 am ET today CCBN
Nov-03-14 05:00PMMindray Announces Third Quarter 2014 Financial Results PR Newswire
Nov-03-14 07:07AMQ3 2014 Mindray Medical International Ltd Earnings Release - After Market Close CCBN
Oct-15-14 08:00AMMindray Medical to Exhibit New Products at Upcoming Medical Equipment Fairs PR Newswire
Oct-14-14 08:00AMMindray to Report Third Quarter 2014 Financial Results on Nov 3, 2014 PR Newswire
Sep-24-14 08:13AMThe Zacks Analyst Blog Highlights: Yingli Green Energy Holding,, Mindray Medical International, Signet Jewelers and Tiffany Zacks
Mindray Medical International Limited develops, manufactures, and markets medical devices worldwide. The company operates in three segments: Patient Monitoring and Life Support Products, In-Vitro Diagnostic Products, and Medical Imaging Systems. The Patient Monitoring and Life Support Products segment offers monitoring devices that track the physiological parameters of patients, such as heart rate, blood pressure, respiration, and temperature. Its products include single and multiple-parameter monitors; mobile and portable multifunction monitors; central stations that can collect and display multiple patient data on a single screen; electro-cardiogram monitoring devices; and veterinary monitoring devices. This segment also provides anesthesia machines; defibrillators; surgical equipment, including surgical beds, and surgical lights ceiling pendants; syringes and infusion pumps; and ventilators. The In-Vitro Diagnostic Products segment provides data and analysis on blood, urine, and other bodily fluid samples for clinical diagnosis and treatment; and in-vitro diagnostic products for laboratories, clinics, and hospitals to perform analysis to detect and quantify substances in patient samples. Its product portfolio consists of hematology analysis products, biochemistry analysis products, immunoassay products, coagulation analysis products, urine sediment analysis products, and microbiology analysis products; and reagents used in in-vitro diagnostic products. The Medical Imaging Systems segment offers ultrasound systems used in medical fields, such as urology, gynecology, obstetrics, and cardiology; digital radiography systems; and magnetic resonance imaging systems. The company also provides orthopedic products, endoscope devices, and healthcare IT solutions. Its markets and sells its products through distributors, as well as directly to hospitals and government agencies. The company was founded in 1991 and is headquartered in Shenzhen, The People's Republic of China.
CompanyRepublic Airways Holdings Inc.
IndustryRegional Airlines
Market Cap650.76MEPS (ttm)1.32
P/E9.90EPS this Y46.00%
Forward P/E8.11EPS next Y18.53%
PEG0.76EPS past 5Y-17.60%
P/S0.47EPS next 5Y13.00%
P/B1.08EPS Q/Q288.90%
Dividend-Sales Q/Q3.30%
Insider Own1.50%Inst Own85.90%
Insider Trans-10.11%Inst Trans3.69%
Short Float2.83%EarningsOct 29/a
Analyst Recom2.50Target Price14.40
Avg Volume534.88K52W Range7.82 - 13.80
Dec-18-14 06:42PMFalling Oil Prices Help Airlines, Truckers at Investor's Business Daily
Dec-12-14 04:49PMREPUBLIC AIRWAYS HOLDINGS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements an EDGAR Online
Dec-11-14 07:18PMRepublic Airways to Expand Partnership with Delta Air Lines Business Wire
Dec-10-14 06:01AMREPUBLIC AIRWAYS HOLDINGS INC Files SEC form 8-K, Other Events EDGAR Online
Dec-08-14 12:10PMRepublic Airways Holdings Reports November 2014 Traffic Business Wire
Dec-02-14 05:31AMHawaiian Holdings (HA) in Focus: Stock Up 5% Zacks
Dec-01-14 05:28AMChina Eastern Airlines Corp (CEA) in Focus: Stock Up 5.8% Zacks
Nov-24-14 06:36PMRepublic Airways' Breakout On Track After Early Scare at Investor's Business Daily
Nov-11-14 10:27AMBest Charts from Successful Investing's Top 14 Picks at Forbes
Nov-11-14 06:04AMChina Eastern Airlines (CEA) Jumps: Stock Gains 6.3% Zacks
Republic Airways Holdings Inc., through its subsidiaries, provides scheduled passenger services. It offers scheduled passenger service on approximately 1,390 flights daily to approximately 118 cities in the U.S. and Canada through fixed-fee flights operated under airline partner brands, including American Eagle, Delta Connection, United Express, and US Airways Express. As of December 31, 2013, the company operated a combined fleet of approximately 258 aircraft. It is also engaged in charter and cargo operations. The company was founded in 1996 and is headquartered in Indianapolis, Indiana.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Willman RyanVP, Corporate ControllerDec 01Sale13.133,39244,53722,000Dec 02 04:10 PM
Heller Wayne CEVP & COONov 28Option Exercise10.19106,7481,087,724162,912Dec 01 05:06 PM
Heller Wayne CEVP & COONov 28Sale13.27149,3481,981,83882,912Dec 01 05:06 PM
Heller Wayne CEVP & COONov 26Sale13.007,40096,200125,512Dec 01 05:06 PM
Willman RyanVP, Corporate ControllerNov 11Sale13.012,71435,30927,000Nov 13 04:23 PM
CompanySangamo Biosciences Inc.
Market Cap1.06BEPS (ttm)-0.46
P/E-EPS this Y-14.30%
Forward P/E-EPS next Y-9.80%
PEG-EPS past 5Y4.40%
P/S28.01EPS next 5Y-
P/B5.03EPS Q/Q0.00%
Dividend-Sales Q/Q117.50%
Insider Own1.70%Inst Own76.00%
Insider Trans1.93%Inst Trans0.07%
Short Float14.98%EarningsOct 22/a
Analyst Recom1.70Target Price25.60
Avg Volume864.76K52W Range9.39 - 24.69
Dec-18-14 09:35AM2014 Healthcare Stock Report Card: Sobek Tracks His Hits and Misses at TheStreet
Dec-17-14 03:56PMIs Sangamo The Next Biotech Stock To Break Out? Benzinga
Dec-12-14 07:31AMSangamo Biosciences (SGMO) Jumps: Stock Rises 7.2% Zacks
Dec-08-14 07:00AMSangamo BioSciences Presents New Data at American Society of Hematology Meeting Demonstrating Broad Application of ZFN Mediated Genome-Editing Approach to Therapeutics for Hemophilia and Lysosomal Storage Disorders PR Newswire
Nov-19-14 07:00AMSangamo BioSciences Presents Study At Society For Neuroscience Meeting Demonstrating In Vivo Reversal Of Huntington's Disease Signs And Symptoms PR Newswire
Nov-18-14 04:02PMSangamo BioSciences Announces Presentation at the 26th Annual Piper Jaffray Healthcare Conference GlobeNewswire
Nov-14-14 11:49AMInsider Trading Alert - CCOI, CRM And SGMO Traded By Insiders at TheStreet
Nov-10-14 09:05AMSangamo BioSciences President and CEO Edward Lanphier to Serve as Chairman of the Alliance for Regenerative Medicine PR Newswire
Nov-04-14 01:04PMSANGAMO BIOSCIENCES INC Financials EDGAR Online Financials
Oct-30-14 08:08PM10-Q for Sangamo BioSciences, Inc. Company Spotlight
Sangamo BioSciences, Inc., a clinical stage biopharmaceutical company, focuses on the research, development, and commercialization of zinc finger DNA-binding proteins (ZFPs) for gene regulation and gene modification in the United States. Its ZFPs could be engineered to make ZFP nucleases (ZFNs) proteins, which could be used to modify DNA sequences in various ways; and ZFP transcription factors (ZFP TFs) proteins could be used to turn genes on or off. The company's principal ZFP therapeutic is SB-728-T, a ZFN-modified autologous T-cell product, which is in Phase II and Phase I/II clinical trials for the treatment of human immunodeficiency virus and acquired immunodeficiency syndrome. It also develops CERE-110 that is in Phase II clinical trial for the treatment of Alzheimer's disease. In addition, the company has ZFP therapeutic pre-clinical stage programs for hemophilia A and B, huntington's disease, and hemoglobinopathies; and proprietary programs in the areas of lysosomal storage disorders. Further, it has ZFP therapeutic research stage programs in the areas of other monogenic diseases, including various immunodeficiencies, as well as central nervous system disorders and cancer immunotherapy. The company has collaboration and license agreements with Shire International GmbH and Biogen Idec Inc.; and strategic partnerships with Sigma-Aldrich Corporation, Dow AgroSciences, LLC, Open Monoclonal Technology, Inc., F. Hoffmann-La Roche Ltd, and Hoffmann-La Roche Inc. Sangamo Biosciences, Inc. was founded in 1995 and is headquartered in Richmond, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LARSON JOHN WILLIAMDirectorDec 15Option Exercise5.9515,00089,250229,660Dec 15 09:23 PM
LANPHIER EDWARD O IIPresident & CEODec 15Option Exercise4.1125,000102,750348,467Dec 15 09:49 PM
LARSON JOHN WILLIAMDirectorDec 15Sale16.2810,000162,829214,660Dec 15 09:23 PM
LANPHIER EDWARD O IIPresident & CEODec 15Sale15.4025,000384,912323,467Dec 15 09:49 PM
Mento Steven JDirectorDec 11Option Exercise4.1010,00041,00035,069Dec 15 08:00 PM
TickerSOL [NYSE]
CompanyReneSola Ltd.
IndustrySemiconductor - Specialized
Market Cap153.78MEPS (ttm)-0.24
P/E-EPS this Y-1.10%
Forward P/E50.33EPS next Y107.90%
PEG-EPS past 5Y-27.00%
P/S0.10EPS next 5Y15.00%
P/B1.05EPS Q/Q94.60%
Dividend-Sales Q/Q-11.20%
Insider Own45.67%Inst Own14.60%
Insider Trans-Inst Trans-7.97%
Short Float11.73%EarningsNov 26/b
Analyst Recom3.50Target Price2.63
Avg Volume1.58M52W Range1.21 - 4.46
Dec-22-14 10:06AMSasol Announces Completion of US$4 Billion Credit Facility for its World-Scale Ethane Cracker and Derivatives Complex in Louisiana PR Newswire
Dec-12-14 08:52AMS.Africa's ANC eyes state sell-off to ease power crunch Reuters
Dec-03-14 04:00PMReneSola (SOL) Ramps up its Operations in North America Zacks
Dec-03-14 06:50AMReneSola Expands into Canada CNW Group
Dec-02-14 05:00AMReneSola Expands North American Operations PR Newswire
Nov-27-14 08:10AMReneSola Incurs Q3 Loss, Cuts Module Shipment Guidance Zacks
Nov-26-14 08:00AMReneSola Ltd Earnings Call scheduled for 8:00 am ET today CCBN
Nov-26-14 07:07AMQ3 2014 ReneSola Ltd Earnings Release - Before Market Open CCBN
Nov-26-14 06:32AMReneSola revenue falls on lower shipments Reuters
Nov-26-14 06:00AMReneSola Ltd Announces Third Quarter 2014 Results PR Newswire
ReneSola Ltd, through its subsidiaries, manufactures and sells various solar power products. It operates through two segments, Wafer, and Cell and Module. The company offers virgin polysilicon; mono crystalline and multi crystalline solar wafers; and photovoltaic cells. It also provides mono crystalline and multi crystalline solar modules for use in various residential, commercial, industrial, and other solar power generation systems. In addition, the company offers wafer processing services. It offers its products to the manufacturers of solar cells and modules, distributors, installers, and end users of solar modules. The company operates in Mainland China, Taiwan, Australia, Singapore, Korea, India, Hong Kong, Japan, Germany, Greece, Belgium, Italy, France, the United States, Spain, Czech Republic, England, the Netherlands, and South Africa. ReneSola Ltd was founded in 2005 and is based in Jiashan, the People's Republic of China.
CompanySunPower Corporation
IndustrySemiconductor - Specialized
Market Cap3.43BEPS (ttm)0.86
P/E30.34EPS this Y122.90%
Forward P/E19.01EPS next Y5.13%
PEG12.64EPS past 5Y19.60%
P/S1.37EPS next 5Y2.40%
P/B2.47EPS Q/Q-72.60%
Dividend-Sales Q/Q0.90%
Insider Own0.30%Inst Own38.80%
Insider Trans-46.83%Inst Trans4.23%
Short Float19.69%EarningsOct 29/b
Analyst Recom2.10Target Price38.87
Avg Volume2.53M52W Range22.75 - 42.07
Dec-20-14 06:04AMSolar players taking different paths to success at USA TODAY
Dec-18-14 09:47AMNew Energy a Little More Insulated to Sharp Drop in Oil than Before Accesswire
Dec-18-14 08:00AMSunPower Invests in the Smart Energy Home PR Newswire
Dec-17-14 04:05PMSunPower and Sunverge Charge Into 2015 with Solar and Battery Storage Offering in the U.S. and Australia PR Newswire
Dec-16-14 05:45PMStock Pops & Drops: SPWR, CROX, GOOGL & ISIS CNBC
Dec-16-14 12:27PM3 Stocks, 3 trades: SPWR, GM & BA CNBC
Dec-16-14 12:19PMSunPower Upgraded As Yieldco Strategy Seen Likely at Investor's Business Daily
Dec-15-14 08:48PMEnergy Software Co. Tendril Emerges Again With SunPower's $20 Million at The Wall Street Journal
Dec-15-14 05:55PMThe Race Is On For Solar Companies To Woo Utilities at Forbes
Dec-15-14 12:14PMSunPower backs Tendril & plans to use its energy software
SunPower Corporation, an energy services company, designs, manufactures, and delivers solar systems to residential, commercial, and utility customers. It operates in three segments: the Americas, the EMEA, and the APAC. The company offers solar power products, including panels, balance of system components, and inverters. It also designs, manufactures, and sells high-performance rooftop and ground-mounted solar power systems, as well as utility-scale photovoltaic power plants. In addition, the company offers operations and maintenance services, including remote monitoring, preventative, and corrective maintenance services, as well as rapid-response outage restoration and inverter repair services. Further, it leases solar power systems to residential customers. The company serves investors, financial institutions, project developers, electric utilities, independent power producers, commercial and governmental entities, production home builders, residential owners, and small commercial building owners. SunPower Corporation was incorporated in 1985 and is headquartered in San Jose, California. SunPower Corporation is a subsidiary of Total Energies Nouvelles Activits USA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WERNER THOMAS HDirector, Pres and CEODec 02Sale25.8525,000646,285182,934Dec 04 05:35 PM
MCDANIEL THOMAS RDirectorNov 11Option Exercise0.002,55302,669Nov 13 07:49 PM
Wood Patrick IIIDirectorNov 11Option Exercise0.002,553026,919Nov 13 07:35 PM
LESJAK CATHERINE ADirectorNov 11Option Exercise0.002,55304,675Nov 13 07:42 PM
Richards Douglas J.EVP, AdministrationNov 10Sale30.221,09533,0918,395Nov 12 05:07 PM